Acetazolamide
- Product NDC
- 62135-608
- 11-digit product format
- 621350608
- Labeler code
- 62135
- Product ID
- 62135-608_2420d256-1179-5cf2-e063-6394a90ae9a2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA205530
- Marketing category
- ANDA
- Marketing start
- 2016-10-27
- Substance
- ACETAZOLAMIDE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acetazolamide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ACETAZOLAMIDE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | O3FX965V0I |
| Rxcui | 197303, 197304 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-608-12 | Acetazolamide | 120 in 1 BOTTLE | TABLET | 120 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-608 | ACETAZOLAMIDE TABLET [CHARTWELL RX, LLC] | 2 | Current NDC, 1 package rows | 20241012_f75bbf55-98ac-4f91-b6fd-17b5ac860e55.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-608-12 | 62135060812 | 120 TABLET in 1 BOTTLE (62135-608-12) | 120 tablet | 2023-05-09 | No | No | Historical |